As filed with the Securities and Exchange Commission on January 14, 1999
Registration No. 333-18781
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-3
Post-Effective Amendment No. 2
To
Registration Statement
Under
The Securities Act of 1933
Trex Medical Corporation
(Exact name of registrant as specified in its charter)
Delaware 06-1439626
(State or other jurisdiction of (IRS Employer Identification Number)
incorporation or organization)
37 Apple Ridge Road
Danbury, Connecticut 06810
(203) 207-4500
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Sandra L. Lambert, Secretary
Trex Medical Corporation
c/o Thermo Electron Corporation
81 Wyman Street
P.O. Box 9046
Waltham, Massachusetts 02454-9046
(781) 622-1000
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies to:
Seth H. Hoogasian, Esq.
General Counsel
Trex Medical Corporation
c/o Thermo Electron Corporation
81 Wyman Street
P.O. Box 9046
Waltham, Massachusetts 02454-9046
(781) 622-1000
----------------------
<PAGE>
Approximate date of commencement of proposed sale to public: As soon as
practicable after the Registration Statement has become effective.
If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, check the following box.
[]
If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with
dividend or interest reinvestment plans, check the following
box. [X]
If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]
If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]
----------------------
This post-effective amendment removes from registration any of the
securities which remained unsold as of the date of the filing of this
post-effective amendment. The registration is hereby terminated.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this Post-Effective Amendment No. 2 to Registration Statement on
Form S-3 to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Danbury, State of Connecticut, on this 14th day of
January, 1999.
TREX MEDICAL CORPORATION
By: /s/ William J. Webb
William J. Webb
President and Chief Executive Officer
Signature Title Date
President and Chief January 14, 1999
/s/ William J. Webb Executive Officer (Principal
William J. Webb Executive Officer)
/s/ Theo Melas-Kyriazi Chief Financial Officer January 14, 1999
Theo Melas-Kyriazi (Principal Financial Officer)
/s/ Paul F. Kelleher* Chief Accounting Officer January 14, 1999
Paul F. Kelleher (Principal Accounting Officer)
/s/ Gary S. Weinstein* Chairman of the Board and January 14, 1999
Gary S. Weinstein Director
/s/ Dr. Elias P. Gyftopoulos* Director January 14, 1999
Dr. Elias P. Gyftopoulos
_____________________________ Director January __, 1999
John T. Keiser
/s/ Dr. James W. May, Jr.* Director January 14, 1999
Dr. James W. May, Jr.
/s/ Hutham S. Olayan* Director January 14, 1999
Hutham S. Olayan
/s/ Firooz Rufeh* Director January 14, 1999
Firooz Rufeh
*By: /s/ Seth H. Hoogasian
Seth H. Hoogasian
Attorney-in-Fact
